FDA: Secukinumab Approved for Hidradenitis SuppurativaByLauren BuchananNovember 1st 2023Secukinumab is the only anti IL-17A inhibitor approved for hidradenitis suppurativa.
Triple-Combination, Fixed-Dose Acne Gel Shows Promise as TreatmentByLauren BuchananFebruary 24th 2023The once-daily, triple-combination gel led to a marked reduction in moderate to severe acne.